New Catheter-Based valve repair could help heart patients avoid surgery
NCT ID NCT03382457
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a device called the Edwards Cardioband FIT, which is used to repair the tricuspid valve in people with tricuspid regurgitation (a leaky heart valve). The device is delivered through a catheter, avoiding open-heart surgery. The trial includes 75 participants with moderate or worse tricuspid regurgitation who still have symptoms despite medical therapy. The goal is to see if the device is safe and effective at reducing the leak and improving symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Edwards Cardioband FIT Valve Repair System (a device implanted via catheter to repair the tricuspid valve)
What this could lead to
If it works, this could offer a less invasive treatment option for people with tricuspid regurgitation, reducing symptoms and the need for open-heart surgery.
What could go wrong
This is an early-stage study with only 75 participants, so results may not apply to everyone. The procedure carries risks like bleeding, infection, or device complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Medical Center /New York Presbyterian Hospital
New York, New York, 10032, United States
-
Heart Hospital Baylor Plano
Plano, Texas, 75093, United States
-
Intermountain Medical Center
Murray, Utah, 84107, United States
-
Lankenau Medical Center
Wynnewood, Pennsylvania, 19096, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Morristown Medical Center
Morristown, New Jersey, 07962, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Oregon Health & Science University
Portland, Oregon, 97293, United States
-
University of Virginia Health System
Charlottesville, Virginia, 22908, United States